Ypsomed Holding AG YPHDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $501.00
- Day Range
- $436.55–436.55
- 52-Week Range
- $354.92–501.00
- Bid/Ask
- $0.01 / $125,231.90
- Shares Outstanding
- 13.15M
- Market Cap
- $5.96B
- Volume/Avg
- 20 / 15
Key Statistics
- Price/Earnings (Normalized)
- 26.49
- Price/Sales
- 6.52
- Dividend Yield (Trailing)
- 1.25%
- Dividend Yield (Forward)
- 1.25%
- Dividend Payment Schedule
- Jul
- Total Yield
- 4.55%
Company Profile
Ypsomed, based in Burgdorf, Switzerland, develops and manufactures self-injection devices like pens, autoinjectors, and infusion systems for global pharma and biotech companies. The company shifted focus to business-to-business injection systems, divesting its diabetes care segment to supply device platforms to pharma partners.The company operates in a market driven by strong growth in biologics, biosimilars, patient self-administration, and GLP-1 therapies for obesity. To meet demand, Ypsomed has embarked on an ambitious capacity expansion program, with capital expenditure reaching approximately 50% of sales in recent years. This investment is partially derisked through customer co-financing, which aligns incentives and secures future volume commitments before launch.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,099
- Website
- https://www.ypsomed.com
Competitors
Valuation
|
Metric
|
YPHDF
|
BDX
|
STVN
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.49 | 13.70 | 33.18 |
Price/Book Value | 6.14 | 1.99 | 3.08 |
Price/Sales | 6.52 | 2.51 | 3.82 |
Price/Cash Flow | 18.62 | 13.44 | 18.48 |
Price/Earnings
YPHDF
BDX
STVN
Financial Strength
|
Metric
|
YPHDF
|
BDX
|
STVN
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.36 | 1.08 |
Current Ratio | 1.07 | 0.94 | 1.61 |
Interest Coverage | 76.55 | 3.53 | 33.87 |
Quick Ratio
YPHDF
BDX
STVN
Profitability
|
Metric
|
YPHDF
|
BDX
|
STVN
|
|---|---|---|---|
Return on Assets (Normalized) | 13.64% | 4.97% | 6.21% |
Return on Equity (Normalized) | 23.71% | 10.63% | 10.50% |
Return on Invested Capital (Normalized) | 18.06% | 7.26% | 8.24% |
Return on Assets
YPHDF
BDX
STVN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|b!lM&$Gq | LOCK|Z% | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|!! | LOCK|mxr@ | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|lWgl%#H | LOCK|Hf$@ | $31B | |||
| ResMed Inc
RMD
| LOCK|bFtGs!S> | LOCK|$wfZ | $31B | |||
| Alcon Inc
ALC
| LOCK|BW?d^& | LOCK|J^!$ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|<<Y!<GbQ | LOCK|Bbz | $26B | |||
| Solventum Corp
SOLV
| LOCK|#hh#&& | LOCK|hQG | $15B | |||
| Baxter International Inc
BAX
| LOCK|@J | LOCK|FmJLs | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|K#!LJw$ | LOCK|%w&q | $11B | |||
| Repligen Corp
RGEN
| LOCK|DzzJrWC$ | LOCK|bKPf | $10B |
United States